CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme ...
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...
US biotech Moderna has chosen the location of its promised new R&D facility in the UK, selecting the Harwell Science Campus in Oxfordshire to site the unit. Harwell houses a 700-acre health tech ...